MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study

VEGFA Adult Vascular Endothelial Growth Factor A Genotype QH426-470 Polymorphism, Single Nucleotide Young Adult 03 medical and health sciences 0302 clinical medicine Gene Frequency Pre-Eclampsia Pregnancy Genetics Humans Genetic Predisposition to Disease Pakistan Internal medicine Methylenetetrahydrofolate Reductase (NADPH2) Variants Factor V Preeclampsia RC31-1245 3. Good health Case-Control Studies MTHFR Female F5 Research Article
DOI: 10.1186/s12881-019-0905-9 Publication Date: 2019-10-23T12:05:36Z
ABSTRACT
Abstract Background To study the role of single nucleotide variants (SNVs) genes related to preeclampsia in Pakistani pregnant women. Methods After ethical approval and getting informed consent; 250 women were enrolled equally divided into two groups (125 preeclamptic cases 125 normotensive women). Demographic details medical history recorded, 10 ml blood sample was obtained for DNA extraction. The tetra-primer amplification refractory mutation system (ARMS) assays developed assessing three genes; F5 , MTHFR VEGFA . An association six SNVs; :c.1601G > A (rs6025), :c.6665A G (rs6027), : c.665C T (rs1801133), c.1286A C (rs1801131), c.-2055A (rs699947) c.*237C (rs3025039) with determined by using different genetic models. Results Genotyping SNVs revealed that patients :c.665C T, have increased susceptibility (CT versus CC/TT: OR = 2.79, 95% CI 1.18–6.59; P* 0.046 CT/TT vs CC: 2.91, 1.29–6.57; 0.0497, overdominant dominant models, respectively), whereas G, (A/G AA/GG: 0.42, 0.21–0.84; 0.038 model) :c.1286A C, (CC AA: 0.36, 0.18–0.72; 0.0392 codominant significantly decreased risk preeclampsia. A, VEGFA: no relationship disease. Conclusion This is first case control describing protective against any world population. In addition, present confirmed gene variations development patients. Further studies may be required better understand complex mechanism
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (65)
CITATIONS (23)